DEFINITIVE PROXY STATEMENT

Company

60 DEGREES PHARMACEUTICALS, INC.

Filed

August 27, 2025

Period of Report

October 8, 2025

Accession Number

0001213900-25-080878

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →